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Abstract 
Erythroblasts proliferate and differentiate in hematopoietic organs within erythroblastic 
islands (EI) composed of erythropoietic progenitor cells attached to a central macrophage. 
This cellular interaction crucially involves the erythroid intercellular adhesion molecule-4 
(ICAM-4) and "v integrin. Because integrins are biologically active as "/! heterodimers 
we asked whether !3 could be a heterodimerization partner of "v integrin in EIs. To this 
end we compared stress erythropoiesis driven by two different mechanisms, namely that 
of integrin !3 deficient (!3-/-) mice that exhibit impaired hemostasis due to platelet 
dysfunction with that of systemically erythropoietin-overexpressing (tg6) mice. While 
compared to the respective wild type controls !3-/- mice had much less erythropoietic 
stimulation than tg6 mice !3-/- blood contained more erythrocytes of a lower maturity 
stage. Unexpectedly, membranes of peripheral erythrocytes from !3-/- mice (but not those 
from either wt control or from tg6 mice) contained calnexin, a chaperone that is normally 
completely lost during terminal differentiation of reticulocytes prior to their release into 
the circulation. In contrast to erythropoietin-overexpressing mice, the erythropoietic 
subpopulations representing orthochromatic erythroblasts and premature reticulocytes as 
well as the number of cells per EI were reduced in !3-/- bone marrow. In conclusion, 
absence of integrin !3 impairs adhesion of the latest erythroid developmental stage to the 
central macrophage of EIs resulting in preterm release of abnormally immature 
erythrocytes into the circulation.  
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Introduction 
Proliferating and differentiating erythroblasts require a specialized microenvironment 
termed erythroblastic island (EI) (2, 14, 34), normally (for review see e.g. (3, 31, 33)) 
composed of a F4/80 expressing central macrophage surrounded by about 5-30 cells from 
nucleated proerythroblasts through multilobulated reticulocytes (28). During 
differentiation orthochromatic erythroblasts extrude their nucleus that is subsequently 
engulfed by the central macrophage, a mechanism crucially requiring macrophage – 
erythroblast interactions (33). Moreover, this interaction enhances proliferation of 
erythroblasts by speeding up the G0/G1 phase to complete more cell divisions per time 
unit and, thus, generating more reticulocytes (14). In addition, erythroblast – erythroblast 
interactions regulate survival of erythroblasts through Fas – FasL interaction (29). In man 
the direct contact between erythroblasts is also essential for homotypic signaling between 
erythroblasts within the EI niche as a mechanism for regulating GATA-1 activity to 
complete terminal differentiation (9).  
The above-mentioned interactions are mediated by a diverse array of adhesion 
molecules. Erythroblast macrophage protein (Emp) was the first molecule described to be 
involved in the attachment of erythroblasts to the central macrophage and to neighboring 
erythroblasts (14). Subsequently "4!1 integrin in erythroblasts and vascular cell adhesion 
molecule 1 (VCAM-1) in central macrophages (39) and erythroid intercellular adhesion 
molecule-4 (ICAM-4, also known as the Landsteiner and Weiner (LW) blood group 
glycoprotein (4)) as well as macrophage "v integrin was found to contribute to the 
erythroblast – macrophage interactions (25). 
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Since it has been shown that "IIb!3 and "v!3 integrins can interact with ICAM-4 
on red blood cells (RBCs) (16, 17), the present study aimed to compare characteristics of 
stress erythropoiesis driven by two different mechanisms, e.g. in integrin !3 deficient 
mice that resemble human Glanzmann thrombasthenia characterized by mild 
gastrointestinal and cutaneous hemorrhage due to impaired platelet aggregation (20) with 
that of Epo overexpressing mice (tg6) mice having independent of oxygen tension about 
10-times elevated Epo plasma levels and hematocrit values of 0.8-0.9 (38). Despite 
having less stimulated erythropoiesis than tg6 mice, peripheral blood of !3 deficient mice 
contained RBCs of a lower maturation stage. Surprisingly, erythrocytes from !3-/-, but not 
from tg6 mice, contained calnexin, an endoplasmatic reticulum glycoprotein chaperone 
that is normally completely lost during terminal RBC differentiation (37). Moreover, the 
erythropoietic subpopulation representing orthochromatic erythroblasts and premature 
reticulocytes as well as the number of cells per EI was reduced in !3-/- bone marrow. 
These findings suggest that !3 integrin could be involved in attachment of late 
developmental stages of RBCs to the EI.  
 
 
Materials and Methods 
Animals. Mice used for the present study were generated previously and genotyped as 
described (20, 38). Integrin !3-/- mice were bred on a 129Sv D3 background and tg6 mice 
on a C57BL6 background. All mice were aged between 4 and 6 months and the 
experiments conformed governmental and institutional guidelines. 
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Analysis of peripheral blood. Hematological parameters were determined with standard 
techniques. Plasma erythropoietin concentrations were measured with EPO-TracTm 125I 
RIA kit (DiaSorin) and RBC osmotic fragility, flexibility and life-span as described (5, 
43). RBC membrane proteins analysis (5) revealed for ß3-/- mice an additional band that 
was analyzed by mass spectrometry (Functional Genomics Center Zürich). Optical 
density ratios between bands 4.1a and 4.1b and the extra band and band 4.2 were 
determined as described (13). RBCs were also analyzed flowcytometrically (cf. below) 
for Annexin V-FITC binding (apoptosis detection kit, PromoKine), reticulocyte number 
(Retic-COUNT, BD Biosciences), remnants of endoplasmatic reticulum (ER-tracker®, 
Invitrogen) in reticulocytes (Retic-COUNT positive red cells) and CD71 and CD44 
expression.  
 
Fluorescence-Activated cell Sorting (FACS) and flow cytometry of hematopoietic 
tissues. Bone marrow and spleen single-cell suspensions were immunostained for 
Ter119, CD71, and CD44 and CD47 (all from BD Biosciences) after blocking cellular Fc 
receptors with 5% rat serum and analyzed using a flow cytometer (FACSCalibur or 
Gallios, Becton Dickinson) and the Winmdi or Kaluza software. Hematopoietic cells 
labeled with CD44 and TER119 antibodies were also sorted (Aria III, 5L, Becton 
Dickinson), transferred onto slides and staining with May-Grunwald solution.    
 
Histological analysis of hematopoietic tissues. Perfusion fixed (4% parformaldehyde, 
PBS) and decalcified bone and spleen sections were stained with Prussian blue, 
Hematoxylin and eosin or, after auto-fluorescence quenching (40), with FITC-labeled 
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anti mouse F4/80 (Abcam) and PE-labeled anti mouse Ter119 antibodies and 4#,6-
Diamidino-2-phenylindole dihydrochloride (DAPI, Sigma) to identify EIs in bone 
marrow. EI density and Ter119 positive cells per EI were determined (cf. legend to fig. 
5A) in 10 randomly selected, non-overlapping fields of bone marrow sections per mouse.  
 Other bone marrow sections were immunostained for fibronectin (rabbit anti-
human fibronectin, ICN/Cappel; goat anti-rabbit IgG, DyLight 649 labeled, Jackson 
ImmunoResearch Lab.), coverslipped using a moviol-based (Calbiochem) embedding 
medium (36) containing 1,4-Diazobicyclo-[2.2.2]-Octan (Sigma) and hardened over night. 
After image acquisition (HPX 120 C, Axioimager.Z2, Axiocam HRm CCD camera, 
Axiovision software version 4.5, Zeiss) average optical density levels (oDL) of single 
bone marrow vessels were determined (MCID Analysis 7.0) by taking into account only 
pixels exceeding an oDL of 45 (20% above average background value) and excluding 
elements with a size below 10 pixels (cf. supplemental fig. 7B). 
 
Analysis of bone structure. Cortical and trabecular microarchitecture of femurs was 
assessed by micro-computed tomography (MicroCT40 (Scanco Medical) scanner as 
described (18, 19, 24). 
 
Statistics. Results are expressed as means +SEM. Statistical significances were assessed 
using a 2-tailed Student t-test for unpaired samples with Bonferroni correction and 
labeled as * = p<0.05, ** = p< 0.01 or *** = p<0.001 when compared to the respective 
wt controls or as # = p<0.05, ## = p< 0.01 or ### = p<0.001 for comparison between !3-/- 
and tg6 mice.  
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Results 
Erythropoiesis is mildly stimulated in integrin !3-/- mice. In line with our previous 
reports (5, 38, 43), average hematocrit of the tg6 mice used here was 0.83 whereas it was 
12% lower in !3-/- but not !3+/- mice compared to wt littermates. (fig. 1A). Accordingly 
in four mice of each genotype, hemoglobin concentration (g/dl: wt: 16.05 ±0.15; !3-/-: 12 
±0.7, p < 0.05) and red cell count (*106/$l: wt: 10.82 ±0.37; !3-/-: 7.7 ±0.89, p < 0.01) 
was reduced in !3-/- mice. Erythrocyte parameters such as MCH (pg: 15 ±0.01; !3-/-: 16 
±0.02, ns) and MCHC (g/dl: wt: 34 ±0.03; !3-/-: 32 ±1, ns) were unchanged suggesting 
normal hemoglobin synthesis. RBC volume was increased in !3-/- mice (MCV (fL): wt: 
44 ±1; !3-/-: 49 ±2, p < 0.05) with a slightly higher scatter in !3-/- mice (RDW: wt: 20.9 
±0.7; !3-/-: 21.3 ±1.1, ns). 
 The 1.5-fold and 5.5-fold splenic enlargement in !3-/- and tg6 mice, compared to 
their respective wt controls, indicates stimulated extramedullary erythropoiesis in both 
genetically modified mouse lines that is, however, much stronger in the Epo-
overexpressing mice (fig. 1B). Accordingly, plasma Epo levels were unaltered in !3-/- 
(!3-/-: 20.49 ±1.45 U/L; wt: 20.35 ±0.85 U/L respectively, n = 10). Flow cytometric 
erythrocyte size determination and peripheral blood smears did not reveal morphological 
alterations in !3-/- mice (supplemental fig. 1A). Prussian blue staining of bone marrow 
and spleen sections did not indicate altered iron storage in !3-/- mice (supplemental fig. 
1B). 
 
  
9 
Red cell survival is normal in integrin !3-/- mice. In wt mice RBC half-life was within 
literature values (30), namely 21.6 ±0.67 days (n = 8). In integrin !3-/- mice half-life was 
slightly (17.9 ±2.96 days (n = 5)) but not significantly (p = 0.29) lower, maybe because 
of the higher data scatter in !3-/- mice compared to their wt littermates (coefficient of 
variation 36.93% vs. 8.99%). This just marginally reduced red cell survival together with 
limited splenomegaly and unaltered plasma Epo levels suggest mild erythropoietic 
stimulation in !3-/- mice.  
 
Mechanical properties of erythrocytes from integrin !3-/- mice are normal. 
Mechanical properties of erythrocytes are age-dependent with young cells being more 
flexible and resistant to osmotic stress. Erythrocytes of tg6 mice were reported to be more 
flexible and having a higher osmotic resistance (5, 43). Compared to wt littermates, !3-/- 
mice showed a trend towards increased erythrocyte flexibility at higher shear forces 
(supplemental fig. 2A) but unchanged osmotic resistance (50% lysis of RBCs: wt: 
0.5581%, !3-/-: 0.5545%, supplemental fig. 2B).   
 
Peripheral erythrocytes of integrin !3-/- mice show a higher degree of immaturity 
than those of tg6 mice. Compared to wt, reticulocyte counts were significantly and, 
more surprisingly, similarly increased in !3-/- and tg6 mice. Maturity of the peripheral red 
cells was therefore assessed by additional measurements (figs. 2 & 3). 
The skewness of the intensity distribution directly impacts the geometric mean (cf. 
fig. 2B) that can be used to estimate reticulocyte age distribution (46, 47). Average 
fluorescence intensity of Retic-COUNT® stained reticulocytes from !3-/- was 
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significantly higher than of those of their wt littermates whereas tg6 reticulocytes had the 
same staining intensity as control mice. Accordingly, Brilliant-Kresyl blue stained blood 
smears appeared more intense and spread in !3-/- than in wt or tg6 reticulocytes 
(supplemental fig. 3). Using flow cytometry, expression of the transferrin receptor CD71 
was assessed because this protein diminishes with erythroblast maturation (23). 
Compared to wt controls a similar and significant increase in cells positive for CD71, was 
observed in !3-/- and tg6 mice. Next, we examined on RBCs expression of the adhesion 
molecule CD44 that might be more specific for late erythropoietic developmental stages 
(6). Compared to wt littermates as well as to tg6 mice !3-/- mice had significantly more 
CD44 positive RBCs. In contrast, RBCs of tg6 mice showed the same CD44 expression 
as their wt controls. Another sign of immaturity are remnants of the endoplasmatic 
reticulum (ER) that were considerably (+50%) more increased in !3-/- than in tg6 RBCs. 
Red cell aging, next to other stresses, results in phosphatidylserine exposure. As reported 
previously (12) tg6 erythrocytes bound significantly more Annexin V whereas !3-/- RBCs 
showed unaltered Annexin V binding (fig. 2A). Tg6 erythrocytes express less CD47 (5), 
a marker that declines with RBC aging (35). In contrast to tg6 RBCs, !3-/- red cells 
displayed increased CD47 expression by about 42% compared to their wt littermates (fig. 
2B). 
 Next, we determined the band 4.1a / 4.1b ratio of RBC ghost proteins that 
increases with RBC aging (22). Figure 3A shows examples of silver stained SDS-
polyacrylamide gel electrophoresis (SDS-PAGE). For both wt strains used the band 4.1a / 
4.1b ratio was within the values reported previously for mice (5, 22). In line with our 
previous work the band 4.1a /4.1b ratio was increased in tg6 mice compared to their wt 
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controls (fig. 3B), which had been interpreted as accelerated aging of the transgenic 
RBCs (5). In contrast, in !3-/- mice the band 4.1a /4.1b ratio was dramatically reduced by 
about 75% suggesting a reduced average age of peripheral !3-/- RBCs.  
 Interestingly, silver-stained SDS-PAGE of RBC membrane extracts from !3-/- 
mice showed an extra band at around 90kD (fig. 3A), which was identified as calnexin 
with a MASCOT’s probability based Mowse score of 291 indicating that the probability 
that this protein is not present in the extra band is smaller than 10-29 %. 16 peptide query 
matches and 9.5% sequence coverage were obtained and mass accuracy for all peptides 
was better than 20.5 ppm (supplemental fig. 4). Calnexin, an endoplasmatic reticulum 
glycoprotein chaperone, is normally completely lost before reticulocytes are released into 
the circulation (37) was absent in tg6 RBC membrane preparations (fig. 3A & 3C) 
implying even abnormal immaturity of the peripheral RBCs from !3-/- mice. These data 
suggest a reduced stability of the erythropoietic niche in !3 deficient mice. 
 
The latest erythroid developmental stage is reduced in bone marrow of !3-/- mice. 
Using the flow cytometric assay developed by Liu et al. (29), we next examined the 
erythroblast differentiation stages in hematopoietic tissues. Based on Ter119 and CD71 
expression, bone marrow and spleen cells were classified as proerythroblast (ProE) and 
cells expressing high levels of Ter119.  
Splenic erythroblasts (Ter119 positive cells) were significantly increased in both 
genetically modified mouse lines (n = 8, all in %: !3+/+: 10.7 ±2.56; !3-/-: 28.6 ±4.85, 
p<0.01 vs. !3+/+; BL6: 7.2 ±2.65; tg6: 66.7 ±2.74, p<0.001 vs. BL6) but not in bone 
marrow (n = 8, all in %: !3+/+: 34.8 ±2.31; !3-/-: 42 ±3.86; BL6: 49.2 ±2.16; tg6: 50.5 
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±2.11). The proportion of the different erythroblast subsets Ery.A, Ery.B and Ery.C 
(supplemental fig. 5) in bone marrow was clearly different between !3-/- and tg6 mice. 
Whereas compared to their respective wt controls the percentage of ProE and Ery.A was 
similar in !3-/- and tg6 mice, the percentage of Ery.B was increased in !3-/- but lower in 
tg6 mice. Conversely, the percentage of the most mature erythroblast subset Ery.C that 
represents orthochromatic erythroblasts as well as premature reticulocytes (29) was 
reduced in !3-/- but increased in tg6 mice (fig. 4A). This finding is in line with more 
immature peripheral red blood cells we found in !3-/- mice. Interestingly, the high 
increase of Ery.C in tg6 mice compared to their wt controls might suggest delayed RBCs 
release from the bone marrow, which fits to our previous report that tg6 RBCs share 
features of young and aged erythrocytes (5). In the spleen of tg6 mice the increase of 
ProE was much more pronounced compared to !3-/- mice (11-fold vs. 4.8-fold) but no 
other differences between both mouse lines were found in this organ (fig. 4B). 
 A study using cultured splenic proerythroblasts and bone marrow cells obtained 
from mice infected with the anemia-inducing strain of Friend leukemia virus (FVA) 
suggests that later erythropoietic developmental stages may resolve better when stained 
with antibodies against CD44 (6). Therefore, we also analyzed the expression of CD44 
on bone marrow and spleen cells of our mice. Compared to Chen et al. (6) our flow-
cytometrically obtained pattern looked differently (supplemental fig. 6). Consequently, 
we sorted the cells and identified their morphology after May-Grunwald staining 
(supplemental fig. 6C). This way, in CD44 and TER119 stained mouse bone marrow 
cells four erythropoietic subopulations could be distinguished (supplemental fig. 6A). 
Subpopulation I corresponded to ProE and Ery.A, II to EryA, III to some EryB and 
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mainly Ery.C as defined by Liu et al. (29) and IV mainly to reticulocytes but also some 
erythrocytes similar to the definition from Chen et al. (6). In spleen cells however 
subpopulations I and II could not be separated reliably (supplemental fig. 6B). Whereas 
the proportion of splenic erythropoietic stages in spleens of !3-/- and tg6 mice was 
similarly altered compared to their respective wt control (fig. 4D), clear differences were 
found in the bone marrow. As for CD71 the most striking differences between both 
genetically modified mouse lines were found in the last erythroid stage (IV, fig. 4C). 
Compared to their non-transgenic littermates the fraction of population IV was reduced to 
about 40% in !3-/- mice whereas in tg6 mice in was increased by about 30%. Moreover 
subpopulation III was increased in !3-/- mice but reduced in tg6 mice although this did 
not reach the level of statistical significance (fig. 4C). Note that erythropoietic 
stimulation resulted in an inversion of the ratio between subpopulation III (or Ery.B) and 
IV (or Ery.C) only in !3-/- but not in tg6 (cf. fig. 4A & C). 
 
!3-/- EIs contain less erythroblasts. Our above-mentioned flow-cytometric data 
prompted us to next visualize bone marrow EIs with ani-F4/80 and anti-Ter119 
antibodies (fig 5A). Compared to respective wt controls, EI density in femur marrow was 
unchanged in !3-/- mice but significantly increased in tg6 mice. However, significantly 
less (-30%) erythroblasts per island were observed in !3-/- whereas in tg6 mice it was 
comparable to wt controls (fig. 5B).  
 
Fibronectin immunoreactivity of bone marrow is increased in !3-/- and decreased in 
tg6 mice. Quantitative immunofluorescence of fibronectin staining in the bone marrow 
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revealed quite stable measurements. Compared to their respective wt controls vessel-
associated fibronectin staining intensity was significantly increased in !3-/- mice but 
decreased in tg6 mice (fig. 6). 
 
Three dimensional bone structure of !3-/- mice is not altered. Epo induces indirectly 
trabecular bone loss (41) to free marrow space for erythroid cell expansion. Mice lacking 
!3 were reported non-quantitatively to have more but dysfunctional osteoclasts resulting 
in increased cortical and trabecular bone mass (32). In contrast, as shown in figure 7 we 
quantified the three-dimensional structure of the femurs using micro-computed 
tomography imaging (18). Using this technique we did not observe significant changes in 
the cortical bone in none of our mice. However, trabecula of tg6 bones showed reduced 
numbers, increased spacing but unaltered thickness. In contrast, !3-/- mice displayed a 
slight non-significant trend towards reduced trabecular spacing and increased trabecular 
number in line with McHugh et al. (32). Hematoxylin and eosin stained bone sections 
showed no obvious differences regarding the trabecular or cortical bone structure in !3-/- 
mice (not shown).  
 
 
Discussion 
We compared a strong erythropoietic stimulus with a weak one to reveal a potential role 
of integrin !3 for EI integrity. Despite having in comparison to wt mice only mildly 
stimulated erythropoiesis (unaltered plasma Epo values, unchanged EI density in bone 
marrow, minor splenic enlargement, normal RBC life-span) integrin !3 deficient mice 
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exhibit peripheral RBCs of a lower maturity grade (more intense RNA staining in 
reticulocytes, increased CD44 and CD47 expression, increased band 4.1a / 4.1b ratio) in 
comparison to tg6 mice with maximally stimulated erythropoiesis. Of note, !3-/- mice 
retain calnexin in their peripheral erythrocytes indicating even abnormal immaturity. 
Moreover, in bone marrow from !3 deficient but not erythropoietin overexpressing mice 
the late stage erythroblasts are reduced. Together with the finding of reduced numbers of 
erythroblasts per EI in !3 deficient mice these observations suggest that integrin !3 might 
play a role in the stabilization of the erythroblastic islands, most likely during the late 
maturation stage just before reticulocyte release. 
Central macrophages of EIs express "v integrin and erythroid ICAM-4 (LW 
glycoprotein) that is critical for EI formation (25). However, integrins, ligands for 
ICAMs, are functional only as heterodimers composed of one " and one ! subunit. 
Whereas ! subunits combine with different " subunits, " subunits bind only one ! 
subunit with the exception of "v, "4 and "6 (21). Thus, the question remained as to the 
binding partners of "v integrin on the central macrophage of EIs. A hint to answer this 
question was the observation that the red cell ICAM-4 can bind "IIb!3 as well as "v!3 
integrin heterodimers, both present on platelets (16, 17). Genetic deficiency of "IIb and 
!3 integrins results in a bleeding disorder known as Glanzmann thromboplasthenia (7) as 
in the !3 integrin deficient mice used here (20). In contrast, ICAM-4 deficient animals do 
not show alterations in hemostasis, hematocrit or hemoglobin levels (25), probably 
because during hemostasis platelet integrins bind to extracelluar matrix molecules such as 
fibrinogen, fibronectin, von Willebrand factor, thrombospondin and vitronectin (11, 21) 
and not ICAM-4. However, binding of RBCs to the forming thrombus requires 
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interaction of ICAM-4 with "IIb!3 and/or "v!3 integrins (16, 17) although this has not 
yet been proven in vivo (25). Our present data suggest an additional function of integrin 
!3, namely, stabilizing EIs as heterodimerization partner of "v integrin on central 
macrophages. This is concluded from the notion that high erythropoietic stimulation 
result in reduced maturity of the reticulocyte population (1), which however contrasts our 
observation that !3 integrin deficient mice with much weaker erythropoietic stimulation 
than tg6 mice exhibit abnormally immature peripheral RBCs (figs. 2, 3), EI’s with 
significantly less Ter119 positive cells (fig. 5B) and a reduced erythroid bone marrow 
population representing orthochromatic erythroblasts and premature reticulocytes (figs. 
4C, 4E). 
It could be shown that different hematopoietic cell lines bind to ICAM-4, which 
involves "4!1 integrin and "v-family integrins but !3 and "v integrin specific antibodies 
failed to reduce binding of these hematopoietic cell lines to ICAM-4 (42). Maybe the 
stable cell lines used in the latter study do not entirely reflect the dynamic in vivo 
situation, an interpretation in line with the fact that the same study also shows that only 6 
out of 12 tested hematopoietic cell lines bound ICAM-4 (42). Moreover, the same group 
showed later that the "v integrin is indeed involved in binding of erythroblasts to the 
central macrophage (25). However, the whole picture might be more complex as "4!1 
integrin can in addition to ICAM-4 (42) also interact with the vascular cell adhesion 
molecule-1 (VCAM-1) within EIs (39). In this case, "4!1 integrin is expressed on 
erythroblasts and VCAM-1 on the central macrophage (39). Another hint for the 
importance of the integrin – ICAM-4 – interaction for RBC production suggests 
expression and secretion of a soluble ICAM-4 isoform by erythroblasts (26) that could 
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compete with the membrane bound ICAM-4 for integrin counterreceptors and thus play a 
role for the final detachment of reticulocytes from the central macrophage. If another 
heterodimerization partner of "v integrin is missing, e.g. !3 as we suggest, ICAM-4 
dependent EI stability could be weakened and, thus, lower concentrations of soluble 
ICAM-4 could result in a preterm release of late stage erythroblasts or premature 
reticulocytes from the EI. Moreover, our data suggest that strong erythropoietic stimuli 
per se such as massive systemic Epo overexpression in tg6 mice do not trigger release of 
abnormally immature reticulocytes (figs. 3, 4C, 5). 
 Adhesion of the whole EI to the extracellular matrix might be important as well. 
Maturating EIs migrate towards the bone marrow sinusoids where young RBCs are 
released into the circulation (48). Whereas in early developmental stages Epo plays the 
predominant role, interactions of differentiating RBCs with the extracellular matrix e.g. 
fibronectin are crucially important for the second phase of maturation (10) and might 
even provide proliferative stimuli for hematopoietic cells (44, 45). The fibronectin 
dependent late phase of RBC maturation correlates with the migration of the EIs towards 
the sinusoids and both mechanisms might be regulated by interplay between integrin !1 
and !3 (8). Using quantitative immunofluorescence we found in !3-/- mice compared to 
their wt controls bone marrow fibronectin to be increased whereas in tg6 mice it was 
decreased (fig. 6). In !3-/- mice increased fibronectin expression could be a compensatory 
mechanism to enhance binding of the premature RBCs, erythroblasts or the whole EI to 
the extracellular matrix to prevent the release of cells of even lower maturity into the 
circulation. Moreover, this compensatory mechanism could in !3-/- mice enhance also the 
second phase of erythroid maturation that requires fribronectin interaction with "4!1 
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integrin (10), which should not be altered in !3-/- mice. This interpretation fits to the 
significant higher fraction of Ery.B in the bone marrow of !3-/- mice (fig. 4A). In parallel, 
more fibronectin could facilitate migration of EIs towards the sinusoids resulting in 
reduced Ery.C (or group IV) population as observed in !3-/- bone marrow (fig. 4A & C). 
Conversely, bone marrow fibronectin staining intensity was decreased in tg6 mice. Tg6 
mice need to fight against the uncontrolled RBC production. Because they cannot escape 
the early stage of erythroid differentiation and expansion due to transgenic Epo 
production reduced fibronectin expression in tg6 mice could represent a compensatory 
mechanism for decelerating / inhibiting the fibronectin-dependent but Epo-independent 
second phase of erythroid differentiation (10) and migration of the EIs towards the 
sinusoids. This would keep the young erythrocytes longer than normal in the bone 
marrow. Indeed, we previously demonstrated that RBCs from tg6 mice share features of 
young as well as senescent red cell (5), which fits to this interpretation.  
 Bone remodeling to reduce trabecular volume density is crucial for erythropoiesis 
and inhibition of osteoclasts blunts the erythropoietic response to Epo (41). Accordingly, 
in tg6 mice bone marrow volume was increased on cost of trabecular number with 
increased trabecular spacing, an observation in line with our previous findings (15). In 
contrast, integrin !3 deficient mice were reported to have compared to wt mice impaired 
bone remodeling as shown by an enhanced density of tailbones that, however, contain 
mainly yellow marrow (27) and histological examples of distal femora suggesting an 
increased bone mass (32). In addition, this latter study shows in !3-/- mice more 
osteoclasts that appear dysfunctional although they retain resorptive capacity when 
cultured on whale dentin. Unfortunately, no quantifications of these observations are 
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provided. Quantitative micro-computed tomography based analysis of femora, however, 
did not reveal significant signs for osteosclerosis in !3-/- mice. On the other hand, altered 
bone remodeling should affect the EI density (41) (that was unchanged in !3-/- mice) 
rather than the number of erythroid progenitors per island (that was reduced in !3-/- 
mice). Thus, it is unlikely that the probably marginally disturbed bone remodeling in !3-/- 
mice could be causal for the observed instability of their EIs.   
 In conclusion, by comparing stress erythropoiesis of Epo overexpressing mice and 
integrin !3-/- mice we discovered a new functional role of integrin !3 for stabilization of 
erythroblastic islands. Our findings suggest that integrin !3 is important during the very 
late stage of red cell production by delaying release of premature reticulocytes. 
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Figure legends 
 
Fig 1.  Comparison of the strength of erythropoietic stimulation in integrin !3 deficient 
and Epo overexpressing (tg6) mice. (A) In homozygous !3 deficient mice the hematocrit 
is slightly but significantly decreased. Systemic overexpression of Epo results in extreme 
hematocrit values as high as 82% in line with our previous reports (5, 38, 43) (n % 5). (B) 
Stimulation of erythropoiesis results in splenic enlargement in both genetically modified 
mouse lines that is, however, stronger in tg6 mice (n % 5).  
 
Fig 2. Analysis of peripheral RBCs in integrin !3-/- and tg6 mice. (A) This bar graph 
shows for both genetically modified mouse lines the fold changes of the parameters in 
relation to their respective wt controls (set to 1). Reticulocyte counts were significantly 
and similarly increased in both !3-/- and tg6 mice but only !3 deficient mice showed a 
significantly higher reticulocyte staining intensity (n % 6). The percentage of CD71 
positive RBCs was similarly increased in !3-/- and tg6 mice (n % 6) whereas the CD44 
positive fraction was significantly increased only in !3-/- mice (n = 5). Accordingly, the 
ER-tracer dye positive reticulocyte faction was higher in !3-/- mice (n = 5). Binding of 
annexin V to RBCs, marking the eryptotic RBC fraction, did not differ significantly 
between !3 deficient mice and their wt controls. In contrast, according to our previous 
findings (12) annexin V binding was significantly increased on tg6 erythrocytes (n = 6). 
(B) In addition, RBCs from !3-/- displayed increased immunoreactivity for CD47 on their 
surface as evident from right-shift of the population (image) that is quantified by the 
geometric mean  (bar graph, n = 4).  
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Fig 3. Silver-stained SDS–polyacrylamide gel electrophoresis of erythrocyte membrane 
proteins. (A) In !3 deficient mice an additional band was detected that was identified as 
calnexin using mass spectroscopy. (B) Quantification of the band 4.1a/4.1b ratio revealed 
in !3 deficient mice a reduction whereas in accordance with our previous study (5) this 
ratio was increased in tg6 (n % 5). (C) Quantification of the calnexin band intensity in 
relation to the band 4.2 intensity revealed practically no signal in tg6 mice whereas it was 
clearly detectable in !3-/- mice (n % 5). 
 
Fig 4. Analysis of erythroblast subsets in bone marrow and spleen. (A) In the bone 
marrow ProE were significantly increased to a similar extend in both !3-/- and tg6 mice. 
Ery.A were not altered whereas Ery.B were significantly increased in !3-/- mice but 
decreased in tg6 mice. The Ery.C population, representing orthochromatic erythroblasts 
and premature reticulocytes, was significantly decreased in !3-/- but increased in tg6 mice 
(n = 5). (B) In the spleen no differences between !3-/- and tg6 mice were found regarding 
the fraction of the different erythroblast subpopulations (n = 5).  
Panel (C) and (D) show the different erythroblast subpopulations after staining with 
FITC-conjugated anti-CD44 and PE-conjugated anti-Ter119 antibodies. (C) In line with 
the findings obtained with CD71 the most obvious difference between !3-/- and tg6 mice 
was the marked decrease in the latest erythropoietic developmental stage (subpopulation 
IV) in !3-/- but an increase in tg6 bone marrow compared to wt controls. Also the pattern 
of the other subpopulations was comparable to that observed with CD71. (D) As for 
CD71, in the spleen there was no difference between !3-/- and tg6 mice regarding the 
erythropoietic subpopulations.   
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Fig 5. Analysis of EIs in bone marrow. (A) Representative image of a bone marrow EI 
with the macrophage labeled with an antibody directed against F4/80 (green) and the 
erythroblasts labeled with an antibody against TER119 (red). Original magnification 
1000x. Only those TER119 positive cells were considered to be associated with a central 
macrophage that were 25% or less of the cell diameter distant from a F4/80 positive cell 
(4 gray squares = cell diameter, yellow square: 25% of the diameter of that cell). (B) 
Quantification of the EI density per 10 fields of view per animal and the number of 
erythroblasts attached to a macrophage. Compared to wt controls there was no difference 
in !3-/- mice regarding EI density whereas in tg6 mice it was significantly increased (left 
panel). In !3-/- mice there was a significant reduction of cells per EI whereas tg6 mice did 
not show a difference compared to their wt controls regarding this parameter (right panel, 
n = 10). 
 
Fig 6. Assessment of local fibronectin expression in bone marrow. (A) Examples of 
immunofluorescence against fibronectin (original magnification 200x). (B) Illustration of 
the quantification procedure. Using an image analyzing system a threshold 20% above 
the average background optical density level (oDL) was defined. A circular sample tool 
was used to measure each single vessel in the images separately. The threshold procedure 
defined the pixels representing each single vessel (red). Then the average oDL of each 
vessel was calculated. (C) These measurements were very stable and revealed in bone 
marrow vessels an increased fibronectin staining intensity in !3-/- mice whereas it was 
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reduced in tg6 mice. Between both wt control groups no differences could be detected (n 
= 4). 
 
Fig 7. Three-dimensional analysis of trabecular bone in the distal femur. (A) 
Representative $CT images of the distal femur of all mouse lines investigated. Trabecular 
bone (black) had been detected user independently by the software as described 
elsewhere  (24). Note the reduced volume density of the trabecular bone in the tg6 
mouse. (B) Quantification of the trabecular bone structure. Trabecular thickness was the 
same among all mouse lines. Tg 6 mice showed a significantly decreased trabecular 
number, which resulted in increased trabecular spacing. This suggests expanded space for 
erythopoietic cells (n % 3). 
 
 
Figure 1
pe
rc
en
ta
ge
A
!3+/+
!3-/-
BL6
tg6
B
pe
rc
en
t 
of
 b
od
y 
w
ei
gh
t
0
10
20
30
40
50
60
70
80
90
*
***
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2 ***
***
!3+/+
!3+/-
!3-/-
BL6
tg6
Figure 2
!3 -/-!3
+/+
ge
om
et
ri
c 
m
ea
n !3+/+
!3-/-
0
5
10
15
20
25
30
35
**
A
!3-/-
tg6
1 2 3 4
reticulocyte count
reticulocyte staining 
intensity (geometric mean)
CD71 positive RBC fraction
CD44 positive RBC fraction
reticulocyte fraction with ER
eryptotic RBC fraction
fold change compared to respective wt control
**
*
*
***
*
**  ##
***  ##
**
*
B
Figure 3
A
B calnexin / band 4.2 ratio
!3-/- tg6
band 4.1a / 4.1b ratio
0
0.1
0.2
0.3
0.4
0.5
0.6
***0
0.1
0.2
0.3
0.4
0.5
0.7
0.8
**
*
###
0.6
C
Calnexin
4.1a
4.1b
 4.2
 !3+/+!3-/-tg6BL6
- 115
- 86.2
kDa
- 50
!3+/+
!3-/-
BL6 tg6
pe
rc
en
ta
ge
D
spleen (CD44)!3+/+
!3-/-
BL6
tg6
0
10
20
30
40
50
60
70
80
90
100
I & II IVIII
***
**
***
C
pe
rc
en
ta
ge
bone marrow (CD44)!3+/+
!3-/-
BL6
tg6
0
10
20
30
40
50
60
70
80
90
I IVII III
**
**
****
*###
##
##
#
pe
rc
en
ta
ge
spleen (CD71)!3+/+
!3-/-
BL6
tg6
0
10
20
30
40
50
60
70
80
90
100 ***
***
*
*
***
***
*
ProE Ery.CEry.A Ery.B
B
A
pe
rc
en
ta
ge
bone marrow (CD71)!3+/+
!3-/-
BL6
tg6
ProE Ery.CEry.A Ery.B0
10
20
30
40
50
60
70
80
90
***
***
*
*
**
###
###
Figure 4
Figure 5
A B
!3+/+
!3-/-
BL6
tg6
EI
s 
/ 
10
 f
ie
ld
s
er
yt
ro
bl
as
ts
 /
 E
I
0
2
4
6
8
10
12
0
2
4
6
8
10
12
14
16
18
*
* !3+/+
!3-/-
BL6
tg6
Figure 6
A
B
!3+/+ !3-/-
tg6BL6
C
0
10
20
30
40
50
60
70
80
90
100
**
**
!3+/+
!3-/-
BL6
tg6
op
ti
ca
l d
en
si
ty
 le
ve
l
image processing
Figure 7
A
B
!3+/+ !3-/-
tg6BL6
!3+/+
!3-/-
BL6
tg6
tr
ab
ec
ul
ar
 t
hi
ck
ne
ss
 (
m
m
)
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
**
tr
ab
ec
ul
ar
 s
pa
ci
ng
 (
m
m
)
0
0.5
1
1.5
2
2.5
3
3.5
4
**
tr
ab
ec
ul
ar
 n
um
be
r 
(m
m
-1
)
1mm
Supplement to “Decreased stability of erythroblastic islands in integrin !3 deficient 
mice” 
 
Zhenghui Wang, et al. 
 
 
Supplemental figures 
 
S-fig 1.  (A) Size (left panel, n = 18) and gross morphology of erythrocytes (original 
magnification 400x, right panel) were not altered in !3-/- mice (cf. also supplementary 
fig. 3). (B) Prussian blue staining (original magnification 400x) revealed compared to wt 
controls no difference in iron deposition neither in bone marrow nor in spleens of !3-/- 
mice. 
 
S-fig 2. (A) Mechanical properties of !3-/- erythrocytes were not significantly altered as 
assessed by recording elongation of the erythrocytes at shear stresses between 0.13 and 
25.25 s-1 (10.1 mPa*s, solution #1) or 0.29 and 58.5 s-1 (23.4 mPa*s, solution #2). Higher 
shear stresses revealed a trend towards increased flexibility in !3-/-mice (n = 6). (B) 
Osmotic fragility of !3-/- RBCs was indistinguishable from that of their wt controls (n " 
6). 
 
S-fig 3. Blood smears were stained with Brillian-Kresyl blue to visualize reticulocytes. 
Shown are selected fields containing an amassment of reticulocytes (labeled with green 
arrowheads). Reticulocytes from !3-/- mice showed more and denser staining. Original 
magnification 1000x.  
 S-fig 4. (A) MASCOT’s probability based Mowse scores of the proteins identified in the 
additional 90kD band found in the gels from !3-/- peripheral RBC membrane preparations 
(cf. fig. 3A). Scores >52 indicate identity or extensive homology (p < 0.05; green hatched 
area indicates non-significant results). Calnexin has a score of 291 indicating that the 
probability that this protein is not present in the extra band is smaller than 10-29 %. 16 
peptide query matches and 9.5% sequence coverage were obtained and mass accuracy for 
all peptides was better than 20.5 ppm. Marked are also all other significant protein hits 
from mice found in the extra band. (B) The whole amino acid sequence of calnexin is 
shown with the identified peptide fragments marked (bold and underlined). 
 
S-fig 5. Bone marrow and spleen cells (shown here: bone marrow) were classified based 
on Ter119 and CD71 expression as proerythroblast (ProE) and cells expressing high 
levels of Ter119. The population pattern was similar for bone marrow and spleen. The 
whole population of Ter119high cells, representing later stages of erythroblast 
development, was further subdivided according to its CD71 expression level and forward 
scatter (FSC). The resulting three subpopulations were identified as Ery.A (Ter119high 
CD71high FSChigh), Ery.B (Ter119high CD71high FSClow) and Ery.C (Ter119high CD71low 
FSClow), corresponding to basophilic, polychromatic and orthochromatic erythroblasts 
and reticulocytes, respectively. 
 
S-fig 6. Flow cytometric analysis of bone marrow (A) and spleen cells (B) after staining 
with fluorescence labeled antibodies against CD44 (FL1) and TER119 (FL2) and 
definition of subpopulations (C). (A) In TER119 positive bone marrow cells four distinct 
subpopulations could be distinguished based on CD44 staining intensity and forward 
scatter (FL1 INT vs. FS INT plots). These populations are labeled I, II, III and IV. Note 
that only in !3-/- mice more cells are found in population III than IV (arrows, cf. also to 
fig. 4C). In contrast, in spleen cells (B) only three subpopulations could be distinguished 
with the CD44 and TER119 antibodies. The population labels correspond to those in (A). 
(C) Cells found primarily in May-Grunwald stained cytospin preparations of the 
subpopulations defined in (A) and (B) after FACS. Subpopulation I corresponded to ProE 
and Ery.A, II to EryA, III to some EryB and mainly Ery.C as defined by Liu et al. (2) and 
IV mainly to reticulocytes but also some erythrocytes similar to the definition from Chen 
et al. (1). 
 
 
Supplemental References 
1. Chen K, Liu J, Heck S, Chasis JA, An X, and Mohandas N. Resolving the 
distinct stages in erythroid differentiation based on dynamic changes in membrane 
protein expression during erythropoiesis. Proc Natl Acad Sci U S A 106: 17413-17418, 
2009. 
2. Liu Y, Pop R, Sadegh C, Brugnara C, Haase VH, and Socolovsky M. 
Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion 
during the erythropoietic stress response in vivo. Blood 108: 123-133, 2006. 
 
 
Suppl. figure 1
A
B
representative blood smear of a  !3-/- mouse
Prussian blue staining
!3-/-!3+/+
!3+/+ !3-/-
fe
m
ur
 m
ar
ro
w
sp
le
en
0
50
100
150
200
250
300
350
400
!3+/+     !3-/-
ge
om
et
ri
c 
m
ea
n
Erythrocyte FSC height
Suppl. figure 2
A
0
5
10
15
20
25
30
0.13 0.25 0.51 1.26 2.53 5.05 12.63 25.25 0.29 0.59 1.17 2.92 5.85 11.7 29.25 58.5
el
on
ga
ti
on
 in
de
x
shear force (Pa)
solution #1 (10.1 mPa*s) solution #2 (23.4 mPa*s)
B
!3+/+
!3-/-
0
25
50
75
100
125
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
% NaCl
%
 h
em
ol
ys
is
!3+/+
!3-/-
osmotic fragility
red cell deformability
Suppl. figure 3
Brilliant-Kresyl blue staining of blood smears
!3+/+ !3-/-
tg6BL6
Suppl. figure 4
LC/ESI/MS/MS analysis of the extra band seen in fig. 3A
1   megkwllcll lvlgtaavea hdghdddaid ieddlddvie evedsksksd astppspkvt
61  ykapvptgev yfadsfdrgs lsgwilskak kddtddeiak ydgkwevdem ketklpgdkg
121 lvlmsrakhh aisaklnkpf lfdtkplivq yevnfqngie cggayvklls ktaelsldqf
181 hdktpytimf gpdkcgedyk lhfifrhknp ktgvyeekha krpdadlkty ftdkkthlyt
241 lilnpdnsfe ilvdqsvvns gnllndmtpp vnpsreiedp edrkpedwde rpkiadpdav
301 kpddwdedap skipdeeatk pegwlddepe yipdpdaekp edwdedmdge weapqianpk
361 cesapgcgvw qrpmidnpny kgkwkppmid npnyqgiwkp rkipnpdffe dlepfkmtpf
421 saiglelwsm tsdiffdnfi isgdrrvvdd wandgwglkk aadgaaepgv vlqmleaaee
481 rpwlwvvyil tvalpvflvi lfccsgkkqs nameykktda pqpdvkdeeg keeeknkrde
541 eeeeekleek qksdaeedgv tgsqdeedsk pkaeedeiln rsprnrkprr e
calnexin
Hsp90 and
platelet glycoprotein 4
acylamino-acid-
releasing enzyme
peptide matches for calnexin
A
B
transferrin
receptor 1
spectrin alpha
Suppl. figure 5
C
D
 7
1
FSC-Height
ProE
Ter 119
Ery.A
Ery.B
Ery.C
Suppl. figure 6
A
!3+/+ !3-/-
tg6BL6
Flow cytometry of CD44 (FL1) and TER119 (FL2) stained bone marrow cells
Suppl. figure 6 cont.
B
!3+/+ !3-/-
tg6BL6
Flow cytometry of CD44 (FL1) and TER119 (FL2) stained spleen cells
Suppl. figure 6 cont.
C
group I
(proerythroblasts and 
basopholic erythroblasts)
group II
(polychomatic erythroblasts)
group III
(orthochomatic erythroblasts)
group IV
(reticulocytes 
and
erythrocytes)
